Literature DB >> 17189797

Effect of inferior-segment Intacs with and without C3-R on keratoconus.

Colin C K Chan1, Munish Sharma, Brian S Boxer Wachler.   

Abstract

PURPOSE: To determine whether corneal collagen cross-linking with riboflavin (C3-R) augments the effect of inferior-segment Intacs (Addition Technology) in the treatment of keratoconus.
SETTING: Private practice, Beverly Hills, California, USA.
METHODS: A retrospective nonrandomized comparative case series comprised 12 eyes of 9 patients who had inferior-segment Intacs placement without C3-R (Intacs-only group) and 13 eyes of 12 patients who had inferior-segment Intacs placement combined with C3-R (Intacs with C3-R group). The 2 groups were matched preoperatively. All patients had inferior-segment Intacs placed with the incision in the steep axis of manifest refraction. Corneal collagen cross-linking with riboflavin was performed after the Intacs segments were inserted. Outcome measures were topographic keratometry values and the lower-upper (L-U) ratio, which is a topographic measure of the degree of keratoconus. Preoperative data were compared to results 1 day postoperatively and measurements at the last postoperative visit.
RESULTS: The Intacs with C3-R group had a significantly greater reduction in cylinder than the Intacs-only group (P<.05). Steep and average keratometry were reduced significantly more in the Intacs with C3-R group (P<.05). There was a greater reduction in L-U ratio in the Intacs with C3-R group (P<.05).
CONCLUSION: The addition of C3-R to the Intacs procedure resulted in greater keratoconus improvements than Intacs insertion alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189797     DOI: 10.1016/j.jcrs.2006.09.012

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  55 in total

1.  Biomechanical property analysis after corneal collagen cross-linking in relation to ultraviolet A irradiation time.

Authors:  Elena Lanchares; María Angeles del Buey; José Angel Cristóbal; Laura Lavilla; Begoña Calvo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

Review 2.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

3.  Intrastromal corneal rings and corneal collagen crosslinking for progressive keratoconus: comparison of two sequences.

Authors:  N Saib; S Bonnel; J-R Fenolland; M Abrieu; C Rambaud; M Berguiga; F Froussart-Maille; J-C Rigal-Sastourne
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

4.  Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

Authors:  Yuntao Zhang; Pinakin Sukthankar; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 5.  New clinical pathways for keratoconus.

Authors:  D M Gore; A J Shortt; B D Allan
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

Review 6.  Treatment strategies for corneal ectasia.

Authors:  Jennifer G Bromley; J Bradley Randleman
Journal:  Curr Opin Ophthalmol       Date:  2010-07       Impact factor: 3.761

Review 7.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

8.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

9.  Intrastromal corneal ring implants for corneal thinning disorders: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-04-01

10.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.